Michael Decter SemBioSys Genetics Inc. SBS-T SELL Sep 23, 2008

Likes the company but doesn't like what has happened to the entire biotech sector. Has largely exited the stock.

Michael Decter

Unlock Rating

$0.510

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Attempting to make insulin from safflower. Diabetes has become an epidemic. This stock will require some patience and could be volatile. Give it 2 or 3 years.

PAST TOP PICK

(A Top Pick Feb 26/07. Down 13.7%.) Manufactures insulin out of plants. Succeeding on every measure. Will spike up on news. He is in this one for the longer haul. Still likes.

Most Recent Experts

Michael Hakes - CFA, MBA

Murray Wealth Group

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Michael Decter SemBioSys Genetics Inc. SBS-T SELL Sep 23, 2008

You might be interested:

SemBioSys Genetics Inc.(SBS-T)

SemBioSys Genetics Inc.(SBS-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals